mavoric: long-term clinical benefit of mogamulizumab in patients with ctcl
Published 2 years ago • 108 plays • Length 0:40Download video MP4
Download video MP3
Similar videos
-
0:59
mavoric: mogamulizumab improves pfs for ctcl
-
2:31
mavoric trial: mogamulizumab for r/r ctc
-
2:50
mogamulizumab for patients with ctcl
-
1:45
a phase i/ii trial of glofitamab monotherapy in r/r mcl
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
0:38
link between blood involvement and hrqol in ctcl patients receiving mogamulizumab
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:19:17
an insider's look: innovations in malignant hematology research
-
2:09
human’s hematology testimonial video
-
21:56
diagnostic algorithms for eosinophilia and mastocytosis
-
1:31
the future of immunotherapies in the ctcl treatment landscape
-
1:24
the long-term safety and efficacy of ibrutinib monotherapy in patients with previously-treated wm
-
1:35
update on phase i study of plamotamab in r/r nhl
-
0:58
mogamulizumab: an exciting antibody for autoimmunity
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
2:18
update on phase i/ii study of glofitamab monotherapy in r/r mcl
-
2:30
zilurgisertib as monotherapy or in combination with ruxolitinib in patients with mf-related anemia
-
2:19
hematology in focus: mgus with clinical significance
-
1:16
the rationale for combining magrolimab with ruxolitinib in myelofibrosis
-
1:53
preclinical research for the future of cellular therapies
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
1:17
globryte: investigating glofitamab monotherapy in patients with r/r mcl